Full-Time

Research and Development Scientist

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$81.7k - $135kAnnually

Mid, Senior

Austin, TX, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Python
R
SQL
Perl
Data Analysis
Snowflake
Requirements
  • PhD, Master’s, or Bachelor’s degree in biochemistry, molecular biology, cellular biology, or a related field.
  • Expertise in next-generation sequencing (NGS) and DNA/RNA molecular biology.
  • Proficiency with PCR, qPCR, multiplex PCR, and digital PCR techniques preferred.
  • Ability to perform basic data and statistical analysis using tools such as R, JMP, or Excel.
  • Experience in epigenetics/methylation, cfDNA/RNA, and NGS data analysis preferred.
  • Proven track record of innovative research and publications in peer-reviewed journals.
  • Strong analytical, problem-solving, and communication skills.
  • Experience in oncology, transplant, NIPT, or liquid biopsy research preferred.
  • Bioinformatics skills, including PERL, Python, SQL, and data warehousing (e.g., Snowflake), are a plus.
  • Skilled in writing protocols, SOPs, and scientific reports.
  • Familiarity with regulated environments and design control is a plus.
Responsibilities
  • Lead research collaborations, handling statements of work, experimental planning, data analysis, reporting, and deliverables.
  • Coordinate with internal teams and serve as a central point for project execution.
  • Act as a subject matter expert on minimal residual disease (MRD) detection and its applications in clinical oncology research.
  • Regularly engage with external partners and present findings at meetings or conferences.
  • Contribute to abstracts, manuscripts, and marketing materials.
  • Stay current with breakthroughs in MRD detection and cancer treatment.
  • Independently plan and execute high-complexity experiments.
  • Mentor junior scientists and document research under a Quality Management System.
  • Adhere to HIPAA/PHI privacy and compliance training.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through precise genetic insights.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

8%

1 year growth

24%

2 year growth

61%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks